Reactome | Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Schema > LiteratureReference > Entries

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib Show undefined attributes

author	[Person:6799003] Sosman, JA [Person:6798904] Kim, KB [Person:6798987] Schuchter, L [Person:6798870] Gonzalez, R [Person:6798967] Pavlick, AC [Person:6799033] Weber, JS [Person:6798943] McArthur, GA [Person:6798890] Hutson, TE [Person:6798948] Moschos, SJ [Person:6798860] Flaherty, KT [Person:6798883] Hersey, P [Person:6798900] Kefford, R [Person:6798916] Lawrence, D [Person:6798970] Puzanov, I [Person:6798928] Lewis, KD [Person:6798814] Amaravadi, RK [Person:6798831] Chmielowski, B [Person:6798918] Lawrence, HJ [Person:6798998] Shyr, Y [Person:6799037] Ye, F [Person:6798931] Li, J [Person:6798960] Nolop, KB [Person:6798926] Lee, RJ [Person:6798895] Joe, AK [Person:6798974] Ribas, A
created	[InstanceEdit:6799067] Rothfels, Karen, 2015-09-21
dbId	6799066
displayName	Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
journal	N. Engl. J. Med.
pages	707-14
pubMedIdentifier	22356324
schemaClass	LiteratureReference
title	Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
url	http://www.ncbi.nlm.nih.gov/pubmed/22356324
volume	366
year	2012

Referrals

(literatureReference)

[Reaction:R-HSA-6802930] Dimerization of BRAF V600E splice variants contributes to BRAF inhibitor resistance

(author)

© 2026 Reactome

Cite Us!